Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
about
Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionCurrent concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemMajor clinical research advances in gynecologic cancer in 2015Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology.An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic reviewProphylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.Reduced Ovarian Cancer Incidence in Women Exposed to Low Dose Ionizing Background Radiation or Radiation to the Ovaries after Treatment for Breast Cancer or Rectosigmoid CancerPathogenesis and heterogeneity of ovarian cancer.BRCA mutation in ovarian cancer: testing, implications and treatment considerations.Options in Prophylactic Surgery to Prevent Ovarian Cancer in High-Risk Women: How New Hypotheses of Fallopian Tube Origin Influence Recommendations.Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management.Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk.Hysterectomy in the Urologist's Practice.Risk-reducing salpingectomy: Let us be opportunistic.Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cancer.Total bilateral salpingectomy versus partial bilateral salpingectomy for permanent sterilization during cesarean delivery.The Fallopian Tube in the 21st Century: When, Why, and How to Consider Removal.Ovarian Cancer Prevention in High-risk Women.Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.Opportunistic salpingectomy at benign gynecological surgery for reducing ovarian cancer risk: a 10-year single centre experience from China and a literature review.Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach.Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study.Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.Ovarian cancer prevention: Time for primetime?Identification of candidate genes associated with tubal origin of high-grade serous ovarian cancer.Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy: Assessment of Possible Complications and Histopathological p53-Signatures.Trends of Opportunistic SalpingectomyBilateral salpingectomy versus bilateral partial salpingectomy during cesarean deliveryBilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG)
P2860
Q26744525-A99A697A-8CE2-4D6C-9F29-115483C784BFQ26748510-C30248B9-ED2D-42CC-B0A0-37792330552AQ28077183-01D04B25-A96A-4DBD-92EA-696738E69660Q33735161-D56A2427-224F-4FE5-95C3-8191DB048E32Q33901361-C4589E3F-163F-4548-81D1-C533A3C12E3AQ36313479-FE09404D-D5A6-4016-8EDB-D2C9025D4104Q36315490-D19A287D-FBB0-4F1D-A012-6EBF8CDA28FAQ36634141-68D0D409-0393-49C9-A5B4-A43420C6A3F2Q37103750-E25728E5-A6D5-4703-A407-9E6FCF61F0CAQ37546692-85427316-32B5-4AC3-A09E-B13F57825DABQ38644661-1FF46E73-6F82-428A-89B7-A2D5AE3A8A9EQ38794773-9F927E51-53E7-4133-A4E4-179752C86960Q38978839-D5081434-DE2F-4855-AD0E-0A447FC00F61Q39105227-EE4D8864-6743-4412-AA8A-E42A7D32198EQ39108647-F76D8F73-7EF1-4F16-A86F-0EDFF94D693BQ39196159-E89E3388-E2BE-4BF4-B75C-F8B3D5F24DDEQ39718281-B1F07239-7299-43D6-A8E4-E7EB363A9E4EQ40065667-33BAB089-69A4-4004-82ED-504E685F8CDEQ43080679-430E04A7-75FC-4F4D-85E8-51A5B6723686Q45068704-95CCDD39-D347-4B37-92B5-49B62F985450Q46109910-301D9E61-8B6C-4E46-A3A8-D449E5F4027EQ47142893-A5CDC882-9EBB-4814-938A-2DF4413A979FQ47386686-20B73CA5-61F5-4BAE-8F80-9209A20BC13EQ48110433-D0FF4517-1BC4-4B2D-AF3A-ECE8CAA24420Q48124146-4A3F4989-9176-417B-B7EF-0410C5660B51Q52724999-5A4D81F6-6F35-4B04-B8B4-E14E5B1F6B2CQ52941950-9C48B30F-E064-4F94-8D40-F7B5186F622CQ53562928-68D23E4F-6E3F-4502-90C9-0B9AC530C79AQ55247501-999F321D-2271-4B23-A964-159AB77C368EQ55493644-4BF432D6-B440-4A64-B716-870870B11764Q55511958-69F15CF4-0991-4A5F-8916-A2DFB8744EBBQ57142465-4A47DF00-35D6-4E18-9914-D1AD5CB099F6Q58694544-898ADE94-2B81-4E1D-8029-4EF7A1AF16A8Q58758992-F08D6C5F-F4F6-4B75-B486-913AAB2FE77E
P2860
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
@ast
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
@en
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
@nl
type
label
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
@ast
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
@en
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
@nl
prefLabel
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
@ast
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
@en
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
@nl
P2093
P2860
P3181
P356
P1433
P1476
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
@en
P2093
C. Bethan Powell
Jeanne Carter
Joan L. Walker
Lee-may Chen
Lynn P. Parker
Mark E. Borowsky
Randall K. Gibb
Victoria L. Bae Jump
P2860
P304
P3181
P356
10.1002/CNCR.29321
P407
P577
2015-07-01T00:00:00Z